Nephro Flash
Nephro Flash 2026 › Nephro Flash Vol-11, No-2, 2026

Recurrent UTIs in the Kidney Transplant Recipients: A Role for Fosfomycin Amid Rising MDR Uropathogens

Recurrent  UTIs: A common clinical problem in kidney transplant  recipients

Urinary tract infections (UTIs) represent one of the most challenging infectious complications following kidney transplantation, accounting for 45%–72% of all infections and 30% of all hospitalizations for sepsis in kidney transplant recipients.1-3  Particularly, recurrent UTIs –  defined as ≥2 UTIs in a 6-month period or ≥3 UTIs in a 12-month period – seem to pose a more common clinical problem in these from the implantation of the kidney graft, the spectrum of the disease, and the broad underlying local and systemic pathophysiological mechanisms.4-6 The clinical significance of recurrent UTIs extends beyond infection itself, adversely affecting graft function, patient quality-of-life, healthcare utilization, and long-term survival.5  Recurrent UTIs after a kidney transplant can increase the risk of impaired graft function and decreased graft survival, and contribute to graft loss and mortality.